Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
Radiotherapy + Durvalumab for Squamous Cell Carcinoma
Recruiting1 awardPhase 1
Aurora, Colorado
This trial is testing a new cancer treatment and studying its safety. Patients must have a certain type of head and neck cancer that has not spread and must be able to have surgery.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.